The FDA approved nivolumab with ipilimumab in adult and pediatric patients with CRC based on data from the phase 3 CHECKMATE-8HW trial.
Approval Alert | Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC
Advertisement
Advertisement
Trending on CancerNetwork
1
Mosunetuzumab Treatment Combo Yields Responses in High-Risk MCL
2
Giredestrant Combo Significantly Boosts PFS in ER+ Advanced Breast Cancer
3
Dara-KRd Regimen Displays Prolonged PFS in Newly Diagnosed Multiple Myeloma
4
Optimizing the Timing of Genetic Testing in Advanced Ovarian Cancer
5
